Fidaxomicin reduces collagen expression in intestinal fibroblasts via platelet-derived growth factor receptor beta and glycogen synthase kinase-3 beta inhibition.

Journal:

Gastroenterology

Published:

2025-05-20

DOI:

10.1053/j.gastro.2025.04.028

Affiliations:

4

Authors:

11

Go to article

Institutions	Authors	Share
UCLA Health, United States of America (USA)	9.000000	0.82
Cedars-Sinai Medical Center (Cedars-Sinai), United States of America (USA)	1.000000	0.09
Lerner Research Institute, Cleveland Clinic, United States of America (USA)	1.000000	0.09

Interested in Clinical Sciences?